The "primary" antiphospholipid syndrome: major clinical and serological features.
about
Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulantDystonia and chorea in acquired systemic disordersThe critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipinThrombophilia and pregnancyCerebrovascular disease associated with antiphospholipid antibodies: more questions than answersThe epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome.Management of the antiphospholipid syndromePathogenic serum IgG anticardiolipin antibodies and the idiotypic networkSuperior mesenteric artery thrombosis associated with antiphospholipid syndrome.Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.Deterioration of renal function in a patient with lupus.Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?The antiphospholipid syndrome: a syndrome in evolutionAnticardiolipin antibodies and renovascular hypertensionLife-threatening right ventricular thrombosis in association with phospholipid antibodies.Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient-A High Suspicion Is Still NeededRenal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patientsThe lung in the antiphospholipid syndrome.Sneddon's syndrome: a comprehensive review of the literatureAntiphospholipid syndrome: an overview.Antiphospholipid antibodies and infections"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndromeAntiphospholipid antibodies and cardiovascular disease.How to treat women with antiphospholipid antibodies in pregnancy?Long term outcome of catastrophic antiphospholipid syndrome survivors.Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndromeAntiphospholipid Syndrome during pregnancy: the state of the artAntiphospholipid syndrome: multiple mechanisms.Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancyThe role of hypercoagulability in the development of osteonecrosis of the femoral head.Thrombus in a normal left ventricleRecent trends in venous thrombosis and pulmonary embolismPrevalence of anticardiolipin antibodies in the elderly British population.
P2860
Q24633473-BB746501-942B-4B7D-A9E3-F6E2E9F23578Q24679812-37934216-0DAB-437D-B0C3-AD2B0BAFD835Q24798707-61AED5A4-A32C-487B-9DF9-6D346D441496Q24801115-98AC5535-CC87-4268-A77D-A5837DB9DD31Q28196276-4A4671B6-76C6-42BE-90E4-F0840F346269Q28379106-3AA17BA4-7784-4038-AA95-185230470435Q33364820-ED8378C4-7786-4833-A98C-B61B6DF42658Q33388194-7D8F1675-8A21-454D-ACA7-20FB30B03A8BQ33391137-6380DF4A-E7B5-4C88-8448-92C763B7FD4BQ33423034-D6593471-F11C-46A7-B8AA-A44072347CA5Q33493244-97AD43E7-DADB-43B2-B0AD-F7547BCE269DQ33559469-BCE7AF48-B376-45BB-AA90-43FA53D4016BQ33564380-E0C4D3AE-752F-4DF6-85CA-FBF1E83110ACQ33564539-E4489A07-AEA2-4ECA-96C8-6CA01223EF6CQ33566071-4DB5CF10-A1C8-4805-BA87-72D0EDE5BEA2Q33566129-1EFFB1EE-1A38-450C-8E88-3BFB7CF2AA7FQ33567393-B6B6A229-7CA1-4AEF-A972-802334C6F191Q33584068-68471760-F787-409B-87CE-E51904E9A67BQ33613382-5AF74AB3-73FA-4BBE-B440-6A959D9ABAAFQ33768066-0728AD5D-47E9-4074-9F5B-B0362A9704E1Q33944778-07F298CC-704E-4628-A4F2-6349A656DB65Q34519511-264A0010-CB2C-42F5-9B84-029FDA42FD6FQ34998203-B84B1071-6F0A-4CB8-844E-BD39505C8FA2Q35099505-D4D619CF-8B33-4F4D-9518-57CCD172B2C4Q35107007-F7FD1E05-84A9-4E19-B8CC-7438BAA066F0Q35250419-433FE8E7-33A4-4710-86BB-6A587C441EC2Q35356556-D3DD44FF-2D05-4AEF-8233-D93776DC44CAQ35549772-573AFCDD-AE8C-4F39-9A6B-0B0985F763FDQ35552789-A6814BE1-64F7-446D-84A4-75AD009DE94EQ35553410-F58768C8-FA88-4D96-87C4-1B0A7593AA6AQ35554870-E8BC69CF-2E9E-4C32-84FD-4A2421D42885Q35756040-F785113E-2922-4ED6-9A3E-F65900E74E40Q35775322-6774A204-B0C8-4F91-8A56-2035070F96D1Q35822631-BBC628F7-A0FA-4411-92C0-34C8CC26B131Q36009039-61510C7A-17A9-4E9D-86AD-1EF73A641802Q36081533-5A29391F-AC37-4EB7-8D23-9D6CD69341D0Q36092684-662C491D-6CBE-4ABD-8AD0-1CD3A8F52C92Q36465700-C298CCD0-F359-4D7F-9C87-4734E6625FCCQ36647304-330328E9-59EA-4248-9E57-F2D123E3AB09Q36681618-6624FEEC-EC45-4CEB-BD0A-69B80EB3E310
P2860
The "primary" antiphospholipid syndrome: major clinical and serological features.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The "primary" antiphospholipid syndrome: major clinical and serological features.
@ast
The "primary" antiphospholipid syndrome: major clinical and serological features.
@en
type
label
The "primary" antiphospholipid syndrome: major clinical and serological features.
@ast
The "primary" antiphospholipid syndrome: major clinical and serological features.
@en
prefLabel
The "primary" antiphospholipid syndrome: major clinical and serological features.
@ast
The "primary" antiphospholipid syndrome: major clinical and serological features.
@en
P2093
P50
P1433
P1476
The "primary" antiphospholipid syndrome: major clinical and serological features
@en
P2093
Ordi-Ros J
Vilardell-Torres M
P304
P407
P50
P577
1989-11-01T00:00:00Z